Show simple item record

Lenalidomide, dexamethasone and alemtuzumab or ofatumumab in high-risk chronic lymphocytic leukaemia: final results of the NCRI CLL210 trial.

dc.contributor.authorPettitt, AR
dc.contributor.authorJackson, R
dc.contributor.authorCicconi, S
dc.contributor.authorPolydoros, F
dc.contributor.authorYap, C
dc.contributor.authorDodd, J
dc.contributor.authorBickerstaff, M
dc.contributor.authorStackpoole, M
dc.contributor.authorKhan, UT
dc.contributor.authorCarruthers, S
dc.contributor.authorOates, M
dc.contributor.authorLin, K
dc.contributor.authorCoupland, SE
dc.contributor.authorMenon, G
dc.contributor.authorKalakonda, N
dc.contributor.authorMcCarthy, H
dc.contributor.authorBloor, A
dc.contributor.authorSchuh, A
dc.contributor.authorDuncombe, A
dc.contributor.authorDearden, C
dc.contributor.authorFegan, C
dc.contributor.authorKennedy, B
dc.contributor.authorWalewska, R
dc.contributor.authorMarshall, S
dc.contributor.authorFox, CP
dc.contributor.authorHillmen, P
dc.date.accessioned2020-03-02T09:54:30Z
dc.date.issued2020-12-01
dc.identifier.citationHaematologica, 2020
dc.identifier.issn0390-6078
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/3518
dc.identifier.eissn1592-8721
dc.identifier.doi10.3324/haematol.2019.230805
dc.formatPrint-Electronic
dc.languageeng
dc.language.isoeng
dc.publisherFERRATA STORTI FOUNDATION
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.titleLenalidomide, dexamethasone and alemtuzumab or ofatumumab in high-risk chronic lymphocytic leukaemia: final results of the NCRI CLL210 trial.
dc.typeJournal Article
dcterms.dateAccepted2020-02-07
rioxxterms.versionofrecord10.3324/haematol.2019.230805
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2020-02-13
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfHaematologica
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical Trials & Statistics Unit
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical Trials & Statistics Unit
pubs.publication-statusPublished
pubs.embargo.termsNot known
icr.researchteamClinical Trials & Statistics Unit
dc.contributor.icrauthorYap, Christina


Files in this item

Thumbnail
Name:
CLL210 manuscript letter to ...
Size:
722.3Kb
Format:
PDF
Description:
Accepted version
View/Open

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0